Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Kinetic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1761742A reveals recombinant lactonase technology for efficient D-pantolactone synthesis, offering cost reduction and supply stability for vitamin B5 manufacturers.
Patent CN105420285B reveals a scalable enzymatic method for producing optically active heptadecene compounds, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Discover the advanced Lewis acid-mediated reduction and enzymatic resolution process for high-purity cis-4-O-protected-2-cyclopentenol derivatives used in immunosuppressants.
Patent CN106520651A details enzymatic L-norvaline production. High purity, scalable process offers supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN102925528B reveals a novel nitrilase-catalyzed route for high-purity levo-praziquantel intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1220702A details a novel enzymatic process for producing high-purity optically active amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Patent CN1993472A details a lipase-catalyzed route for chiral 3-hydroxy acids, offering cost reduction in API manufacturing and superior supply chain reliability.
Novel lipase mutant enhances Pregabalin intermediate synthesis efficiency and purity. Cost-effective biocatalytic solution for pharmaceutical manufacturing supply chains.
Patent CN112481320B details a novel recombinant lactamase for producing optically pure (-)-γ-lactam. This breakthrough offers superior stability and stereoselectivity for antiviral drug synthesis.
Patent CN110066835B details a novel lipase resolution process for agrochemical intermediates, offering superior enantioselectivity and cost-effective manufacturing solutions.
Patent CN112813131A reveals a high-efficiency carboxylesterase for producing Edoxaban intermediates with superior substrate tolerance and optical purity.
Patent CN110055297B details a novel esterase for resolving (R,S)-5-caprolactone with >98% ee. Discover cost-effective biocatalytic routes for high-purity flavor intermediates.
Novel catalytic route for posaconazole intermediate ensuring high purity and cost efficiency for pharmaceutical supply chains globally. This report analyzes patent CN115448911B for strategic sourcing.
Patent CN100558905C details a lipase-based resolution for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel biocatalytic route for l-menthol using Bacillus subtilis ECU0554. High substrate tolerance up to 500mM and >96% ee. Ideal for flavor and pharma intermediates.
Advanced enzymatic resolution synthesis for chiral antifungal intermediates. Cost-effective, scalable production of high-purity pharmaceutical ingredients with superior stereocontrol.
Patent CN101538542B reveals a novel Pseudomonas esterase for high-purity mandelic acid. This biocatalytic route offers significant cost reduction and supply chain reliability for chiral intermediates.
Patent CN116376872A reveals high-efficiency esterase mutants for (S)-3-cyclohexene-1-carboxylic acid, offering cost reduction and scalable biocatalysis for anticoagulant manufacturing.
Novel enzymatic resolution process ensures greater than 99 percent ee value. Cost-effective Raney nickel catalyst reduces manufacturing expenses for reliable supply chain partners.
Patent CN117106845A reveals enzymatic resolution for chiral pyridine diols. This method offers mild conditions and high atom economy for pharmaceutical intermediate manufacturing supply chains.